Cargando…

Using an optimized generative model to infer the progression of complications in type 2 diabetes patients

BACKGROUND: People live a long time in pre-diabetes/early diabetes without a formal diagnosis or management. Heterogeneity of progression coupled with deficiencies in electronic health records related to incomplete data, discrete events, and irregular event intervals make identification of pre-diabe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoxia, Lin, Yifei, Xiong, Yun, Zhang, Suhua, He, Yanming, He, Yuqing, Zhang, Zhikun, Plasek, Joseph M., Zhou, Li, Bates, David W., Tang, Chunlei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250218/
https://www.ncbi.nlm.nih.gov/pubmed/35778708
http://dx.doi.org/10.1186/s12911-022-01915-5
_version_ 1784739762305761280
author Wang, Xiaoxia
Lin, Yifei
Xiong, Yun
Zhang, Suhua
He, Yanming
He, Yuqing
Zhang, Zhikun
Plasek, Joseph M.
Zhou, Li
Bates, David W.
Tang, Chunlei
author_facet Wang, Xiaoxia
Lin, Yifei
Xiong, Yun
Zhang, Suhua
He, Yanming
He, Yuqing
Zhang, Zhikun
Plasek, Joseph M.
Zhou, Li
Bates, David W.
Tang, Chunlei
author_sort Wang, Xiaoxia
collection PubMed
description BACKGROUND: People live a long time in pre-diabetes/early diabetes without a formal diagnosis or management. Heterogeneity of progression coupled with deficiencies in electronic health records related to incomplete data, discrete events, and irregular event intervals make identification of pre-diabetes and critical points of diabetes progression challenging. METHODS: We utilized longitudinal electronic health records of 9298 patients with type 2 diabetes or prediabetes from 2005 to 2016 from a large regional healthcare delivery network in China. We optimized a generative Markov-Bayesian-based model to generate 5000 synthetic illness trajectories. The synthetic data were manually reviewed by endocrinologists. RESULTS: We build an optimized generative progression model for type 2 diabetes using anchor information to reduce the number of parameters learning in the third layer of the model from [Formula: see text] to [Formula: see text] , where [Formula: see text] is the number of clinical findings, [Formula: see text] is the number of complications, [Formula: see text] is the number of anchors. Based on this model, we infer the relationships between progression stages, the onset of complication categories, and the associated diagnoses during the whole progression of type 2 diabetes using electronic health records. DISCUSSION: Our findings indicate that 55.3% of single complications and 31.8% of complication patterns could be predicted early and managed appropriately to potentially delay (as it is a progressive disease) or prevented (by lifestyle modifications that keep patient from developing/triggering diabetes in the first place). CONCLUSIONS: The full type 2 diabetes patient trajectories generated by the chronic disease progression model can counter a lack of real-world evidence of desired longitudinal timeframe while facilitating population health management.
format Online
Article
Text
id pubmed-9250218
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92502182022-07-03 Using an optimized generative model to infer the progression of complications in type 2 diabetes patients Wang, Xiaoxia Lin, Yifei Xiong, Yun Zhang, Suhua He, Yanming He, Yuqing Zhang, Zhikun Plasek, Joseph M. Zhou, Li Bates, David W. Tang, Chunlei BMC Med Inform Decis Mak Research BACKGROUND: People live a long time in pre-diabetes/early diabetes without a formal diagnosis or management. Heterogeneity of progression coupled with deficiencies in electronic health records related to incomplete data, discrete events, and irregular event intervals make identification of pre-diabetes and critical points of diabetes progression challenging. METHODS: We utilized longitudinal electronic health records of 9298 patients with type 2 diabetes or prediabetes from 2005 to 2016 from a large regional healthcare delivery network in China. We optimized a generative Markov-Bayesian-based model to generate 5000 synthetic illness trajectories. The synthetic data were manually reviewed by endocrinologists. RESULTS: We build an optimized generative progression model for type 2 diabetes using anchor information to reduce the number of parameters learning in the third layer of the model from [Formula: see text] to [Formula: see text] , where [Formula: see text] is the number of clinical findings, [Formula: see text] is the number of complications, [Formula: see text] is the number of anchors. Based on this model, we infer the relationships between progression stages, the onset of complication categories, and the associated diagnoses during the whole progression of type 2 diabetes using electronic health records. DISCUSSION: Our findings indicate that 55.3% of single complications and 31.8% of complication patterns could be predicted early and managed appropriately to potentially delay (as it is a progressive disease) or prevented (by lifestyle modifications that keep patient from developing/triggering diabetes in the first place). CONCLUSIONS: The full type 2 diabetes patient trajectories generated by the chronic disease progression model can counter a lack of real-world evidence of desired longitudinal timeframe while facilitating population health management. BioMed Central 2022-07-01 /pmc/articles/PMC9250218/ /pubmed/35778708 http://dx.doi.org/10.1186/s12911-022-01915-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Xiaoxia
Lin, Yifei
Xiong, Yun
Zhang, Suhua
He, Yanming
He, Yuqing
Zhang, Zhikun
Plasek, Joseph M.
Zhou, Li
Bates, David W.
Tang, Chunlei
Using an optimized generative model to infer the progression of complications in type 2 diabetes patients
title Using an optimized generative model to infer the progression of complications in type 2 diabetes patients
title_full Using an optimized generative model to infer the progression of complications in type 2 diabetes patients
title_fullStr Using an optimized generative model to infer the progression of complications in type 2 diabetes patients
title_full_unstemmed Using an optimized generative model to infer the progression of complications in type 2 diabetes patients
title_short Using an optimized generative model to infer the progression of complications in type 2 diabetes patients
title_sort using an optimized generative model to infer the progression of complications in type 2 diabetes patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250218/
https://www.ncbi.nlm.nih.gov/pubmed/35778708
http://dx.doi.org/10.1186/s12911-022-01915-5
work_keys_str_mv AT wangxiaoxia usinganoptimizedgenerativemodeltoinfertheprogressionofcomplicationsintype2diabetespatients
AT linyifei usinganoptimizedgenerativemodeltoinfertheprogressionofcomplicationsintype2diabetespatients
AT xiongyun usinganoptimizedgenerativemodeltoinfertheprogressionofcomplicationsintype2diabetespatients
AT zhangsuhua usinganoptimizedgenerativemodeltoinfertheprogressionofcomplicationsintype2diabetespatients
AT heyanming usinganoptimizedgenerativemodeltoinfertheprogressionofcomplicationsintype2diabetespatients
AT heyuqing usinganoptimizedgenerativemodeltoinfertheprogressionofcomplicationsintype2diabetespatients
AT zhangzhikun usinganoptimizedgenerativemodeltoinfertheprogressionofcomplicationsintype2diabetespatients
AT plasekjosephm usinganoptimizedgenerativemodeltoinfertheprogressionofcomplicationsintype2diabetespatients
AT zhouli usinganoptimizedgenerativemodeltoinfertheprogressionofcomplicationsintype2diabetespatients
AT batesdavidw usinganoptimizedgenerativemodeltoinfertheprogressionofcomplicationsintype2diabetespatients
AT tangchunlei usinganoptimizedgenerativemodeltoinfertheprogressionofcomplicationsintype2diabetespatients